Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/16/2025

Management of Elderly Female with Influenza A and Severe Hypoxia

Immediate Oxygen Management

  • Administer high-flow oxygen via nasal cannula to maintain SpO2 ≥92% and PaO2 ≥8 kPa in patients with severe hypoxia, as recommended by the British Thoracic Society 1, 3, 4
  • High concentrations of oxygen can be safely given in uncomplicated pneumonia without concern for oxygen toxicity, according to the Journal of Infection 1, 3
  • If the patient has known COPD, obtain arterial blood gas measurements immediately to guide oxygen therapy and assess for CO2 retention, as suggested by the Journal of Infection 1, 3, 4
  • Consider non-invasive ventilation (NIV) if the patient has COPD with ventilatory failure, though NIV has a high failure rate (77%) in influenza-related respiratory failure, as reported by the Journal of Infection 1, 3

Severity Assessment and ICU Consideration

  • Calculate CURB-65 score immediately (Confusion, Urea >7 mmol/L, Respiratory rate ≥30/min, Blood pressure <90/60 mmHg, Age ≥65 years) to assess severity, as recommended by the British Thoracic Society 2
  • Consider ICU/HDU transfer if CURB-65 score is 4 or 5, or if there is persisting hypoxia with PaO2 <8 kPa despite maximal oxygen, as suggested by the Thorax journal 2, 5, 6
  • Consider ICU/HDU transfer if progressive hypercapnia develops, severe acidosis (pH <7.26) occurs, or septic shock develops, as recommended by the Journal of Infection 2, 7

Antiviral Therapy

  • Start oseltamivir 75 mg orally twice daily for 5 days immediately, even if beyond 48 hours of symptom onset, as recommended by the Journal of Infection 3, 4, 7
  • Reduce dose to 75 mg once daily if creatinine clearance is <30 mL/minute, as suggested by the Journal of Infection 3, 4, 7
  • Elderly patients may not mount an adequate febrile response but still benefit from antiviral treatment, according to the Journal of Infection 3, 4, 7

Antibiotic Coverage for Bacterial Superinfection

  • Start empiric antibiotics immediately for presumed bacterial superinfection given the severity of hypoxia, as recommended by the Journal of Infection 1, 2, 5
  • First-line: Co-amoxiclav (amoxicillin-clavulanate) to cover Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae, as suggested by Praxis Medical Insights 5
  • Alternative for beta-lactam intolerance: Doxycycline, as recommended by Praxis Medical Insights 5

Diagnostic Workup

  • Obtain immediately: full blood count, urea and electrolytes, liver function tests, C-reactive protein, chest radiograph, and arterial blood gas if SpO2 <92% on room air, as recommended by the Thorax journal and Praxis Medical Insights 2, 6
  • For severe pneumonia (CURB-65 ≥3 or bilateral infiltrates): blood cultures before antibiotics, pneumococcal urine antigen, and sputum Gram stain and culture if able to expectorate purulent samples, as suggested by the Journal of Infection and Thorax journal 1, 2

Monitoring Protocol

  • Monitor vital signs at least twice daily, more frequently given oxygen requirement: temperature, respiratory rate, pulse, blood pressure, mental status, oxygen saturation, and inspired oxygen concentration, as recommended by the Journal of Infection and Praxis Medical Insights 1, 3, 4, 6, 8
  • Use Early Warning Score system for systematic tracking, as suggested by the Journal of Infection 4

Additional Supportive Care

  • Assess for volume depletion and cardiac complications; provide IV fluids as needed, as recommended by the Journal of Infection 1, 3, 4, 7
  • Provide nutritional support given severe illness, as suggested by the Journal of Infection 1, 3, 4, 7
  • If COPD exacerbation is present, add systemic corticosteroids (prednisone 40 mg daily for 5 days) and short-acting bronchodilators, as recommended by Praxis Medical Insights 5

Critical Pitfalls to Avoid

  • Do not delay antibiotics waiting for microbiological confirmation given the high mortality risk in elderly patients with severe hypoxia, as recommended by the Journal of Infection and Thorax journal 1, 2, 5
  • Do not rely on NIV as definitive therapy – it fails in 77-94% of influenza patients with respiratory failure and should only be considered as a bridge to intubation when ICU beds are limited, as reported by the Journal of Infection 1, 3
  • Do not withhold oseltamivir based on symptom duration in this severely ill, hospitalized elderly patient, as recommended by the Journal of Infection 3, 4, 7
  • Do not discharge until clinically stable – patients should not have ≥2 of these criteria: temperature >37.8°C, heart rate >100/min, respiratory rate ≥24/min, systolic BP <90 mmHg, SpO2 <90%, inability to maintain oral intake, or abnormal mental status, as suggested by the Journal of Infection and Praxis Medical Insights 1, 3, 4, 7, 8